Tumor-specific but immunosuppressive CD39<sup>+</sup>CD8<sup>+</sup> T cells exhibit double-faceted roles in clear cell renal cell carcinoma.
Ontology highlight
ABSTRACT: CD39+CD8+ T cells are known as tumor-antigen-specific cells among CD8+ tumor-infiltrating lymphocytes (TILs). However, CD39+CD8+ T cells also reportedly exhibit immunosuppressive activity in hypoxic tumor models. Here, we investigate CD39+CD8+ TILs in clear cell renal cell carcinoma (ccRCC), a Von Hippel-Lindau (VHL) mutation-associated hypoxic tumor. Single-cell analyses confirm that CD39+CD8+ cells are a terminally exhausted subset of tumor-specific CD8+ TILs. CD39+CD8+ T cell development is directly induced by cAMP and T cell receptor (TCR) signaling. Analysis of a renal cell carcinoma (RCC) cohort reveals that the proportion of CD39+CD8+
SUBMITTER: Lee YJ
PROVIDER: S-EPMC12629791 | biostudies-literature | 2025 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA